PWUP
Aspire Biopharma Holdings, Inc.
Biopharmaceutical company developing patent-protected sublingual drug delivery technology; completed merger with PowerUp Acquisition Corp (SPAC) on February 17, 2025; began trading as ASBP on February 20, 2025
CUSIP: G7207P103HealthcareUS1 holder
Total Value
$517.4K
Total Shares
46.9K
Net Share Change
+46.9K
Activity
1 buying
Investor
Value
Shares
Weight
Change
FPA Crescent Fund
$517.4K46.9K sharesNEW